Cotización CureVac NV - CVAC

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Último Precio

3.015

Postura de Compra

3.01

Postura de Venta

3.02

Volume Operado de la Acción

26,576

2.97 Rango del Día 3.02

2.215 Rango de 52 semanas 6.34

Capitalización de Mercado [m]

675.326M

Precio Anterior

2.98

Precio de Apertura

2.98

Hora

242

3.015

Última hora de negociación

09:16:35

Volumen financiero

US$ 79,701

Precio Promedio Ponderado

2.999

Volumen promedio (3 m)

545,378

Acciones en circulación

223,988,675

Rendimiento del Dividendo

Ratio Precio/Utilidad

-2.56

Beneficio por acción (BPA)

-1.16

turnover

61.71M

Beneficio neto

-260.17M

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-gen... CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-generation COVID-19 vaccine. CureVac's first attempt to develop a COVID-19 vaccine did not have sufficient efficacy data, and its trials were discontinued in October 2021. The company's other pipeline candidates include mRNA vaccines for influenza, rabies, and malaria. Additionally, CureVac is in the early stages of development for oncology and molecular therapies spanning tumors, liver, ocular, and lung diseases. Mostrar más

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sitio web

www.curevac.com

Sede

Tubingen, Deu

Fundado

CureVac NV is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CVAC. The last closing price for CureVac NV was US$2.98. Over the last year, CureVac NV shares have traded in a share price range of US$ 2.215 to US$ 6.34.

CureVac NV currently has 223,988,675 shares in issue. The market capitalisation of CureVac NV is US$667.49 million. CureVac NV has a price to earnings ratio (PE ratio) of -2.56.

Form 144 - Report of proposed sale of securities

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0.065	2.20338983051	2.95	3.07	2.9	286328	2.98884057	CS
4	0.105	3.60824742268	2.91	3.44	2.87	439535	3.11939595	CS
12	-0.505	-14.3465909091	3.52	3.87	2.695	545378	3.32024661	CS
26	-0.095	-3.05466237942	3.11	5.28	2.215	925046	3.47671326	CS
52	-3.215	-51.6051364366	6.23	6.34	2.215	916136	3.80358836	CS
156	-40.965	-93.1446111869	43.98	50.09	2.215	736953	10.77278982	CS
260	-81.975	-96.4525238263	84.99	151.8	2.215	806198	34.57121063	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
OTRKOntrak Inc	US$ 4.937 (171.26%)	54.14M
ALCEAlternus Clean Energy Inc	US$ 0.2171 (44.83%)	86.14M
BPTHBio Path Holdings Inc	US$ 1.1817 (38.81%)	54.23M
NMHINatures Miracle Holding Inc	US$ 0.1867 (37.17%)	91.65M
AGRIAgriFORCE Growing Systems Ltd	US$ 0.0628 (30.83%)	19.43M
SOBRSOBR Safe Inc	US$ 6.5701 (-34.95%)	578.84k
ZJKZJK Industrial Company Ltd	US$ 4.845 (-28.75%)	225.76k
DBGIDigital Brands Group Inc	US$ 0.2062 (-27.14%)	1.17M
CETXCemtrex Inc	US$ 1.02 (-25.55%)	6.5M
MTCMMTec Inc	US$ 0.436 (-24.55%)	4.97M
NMHINatures Miracle Holding Inc	US$ 0.1867 (37.17%)	91.65M
ALCEAlternus Clean Energy Inc	US$ 0.2171 (44.83%)	86.14M
NVDANVIDIA Corporation	US$ 131.481 (2.94%)	74.73M
BPTHBio Path Holdings Inc	US$ 1.1817 (38.81%)	54.23M
OTRKOntrak Inc	US$ 4.937 (171.26%)	54.14M